|
Armed
For Sugar Fighting
While India takes it place as the diabetic capital of the
world, little has changed in the delivery methods for treatment.
Insulin is still injected, making it a tough pill to swallow
for those who fear needles or have harried lifestyles. Deepali
Gupta explores the delivery mechanisms under consideration.
Perlecan
Pharma's DRL 11605 enters Phase I clinical trials
Perlecan Pharma announced the commencement of Phase I clinical
trials of its new generation pan-PPAR activator drug candidate
DRL 11605 in Canada. The drug candidate is being developed
for the treatment of obesity with or without accompanying
diabetes and lipid disorders.
Production
of Antibodies
Dr Waman V Lawate gives us an account on the different methods
of production of antibodies against a wide range of antigens.
|
